⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16103901 | 1.00 | — | — | |
| SCHEMBL13666967 | 1.00 | — | — | |
| SCHEMBL13954515 | 0.83 | KDM4E (0.41) | — | |
| SCHEMBL936834 | 0.79 | — | — | |
| SCHEMBL13101176 | 0.79 | — | — | |
| SCHEMBL3990275 | 0.79 | — | — | |
| SCHEMBL12246397 | 0.78 | KDM4E (0.36) | — | |
| SCHEMBL24866666 | 0.77 | — | — | |
| SCHEMBL3537241 | 0.77 | — | — | |
| SCHEMBL23288380 | 0.77 | ALDH1A1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109655540-B | Method for analyzing related substances of salmon calcitonin nasal spray | 银谷制药有限责任公司 | 2022-08-30 | — | — | CN | claimed |
| US-7585846-B2 | Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof | UNIVERSITY OF ROCHESTER (US) | 2009-09-08 | — | — | US | claimed |
| US-6335176-B1 | REAGENT IS SUCCINIMIDYL MOIETY LINKED TO KINASE SUBSTRATE; CAN BE LINKED TO FREE PRIMARY OR SECONDARY AMINE IN COMPOUND TO BE PHOSPHORYLATED | PHARMACOPEIA, INC. | 2002-01-01 | — | — | US | claimed |
| CN-111558049-B | Methylene carbamate linkers for use with target-drug conjugates | 西雅图基因公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-111569086-B | Methylene carbamate linkers for use with target-drug conjugates | 西雅图基因公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-4212181-A2 | METHYLENE CARBAMATE LINKERS FOR USE WITH TARGETED-DRUG CONJUGATES | Seagen Inc. (US) | 2023-07-19 | — | — | EP | disclosed |
| CN-109655540-B | Method for analyzing related substances of salmon calcitonin nasal spray | 银谷制药有限责任公司 | 2022-08-30 | — | — | CN | disclosed |
| EP-3283461-B1 | NOVEL COUMARIN DERIVATIVE FOR DETECTION OF CYSTEINE AND PROCESS FOR THE SYNTHESIS THEREOF | COUNCIL SCIENT IND RES (IN) | 2022-03-30 | — | — | EP | disclosed |
| US-20220054650-A1 | Methylene Carbamate Linkers for use with Targeted-Drug Conjugates | SEATTLE GENETICS, INC. | 2022-02-24 | — | — | US | disclosed |
| US-11116847-B2 | Methylene carbamate linkers for use with targeted-drug conjugates | SEAGEN INC. (US) | 2021-09-14 | — | — | US | disclosed |
| US-10758498-B2 | Method of decreasing protein-aldehyde adducts by administering a mixed disulfide of n-acetylcysteine and propyl mercaptan, propenyl mercaptan, or allyl mercaptan | SOCTRONICS TECHNOLOGIES PRIVATE LIMITED (IN) | 2020-09-01 | — | — | US | disclosed |
| WO-2006083692-A2 | METHODS OF IDENTIFYING MODULATORS OF BROMODOMAINS | MOUNT SINAI SCHOOOL OF MEDICINE (US) | 2006-08-10 | — | — | WO | disclosed |
| US-20030119909-A1 | Stabilized medicament containing cysteinyl derivatives | STANISLAUS, FRITZ (DE) | 2003-06-26 | — | — | US | disclosed |
| US-20020037855-A1 | Stabilized medicament containing cysteinyl derivatives | STANISLAUS FRITZ (DE) | 2002-03-28 | — | — | US | disclosed |
| EP-0850924-B1 | Aromatic diselenides and selenosulphides for use as antioxidant agents | OXIS ISLE OF MAN LTD (GB) | 2001-03-14 | — | — | EP | disclosed |
| US-6040328-A | ANTIOXIDANT AGENTS HAVING CYTOPROTECTING ACTIVITY, AND WATER SOLUBLE | OXIS INTERNATIONAL S.A. (US) | 2000-03-21 | — | — | US | disclosed |
| US-5973009-A | ANTIOXIDANT AND CYTOPROTECTING ACTIVITY | OXIS INTERNATIONAL S.A. (US) | 1999-10-26 | — | — | US | disclosed |
| EP-0850924-A1 | Aromatic diselenides and selenosulphides for use as antioxidant agents | OXIS Isle of Man, Limited (GB) | 1998-07-01 | — | — | EP | disclosed |
| US-5723501-A | Pharmaceutical compositions containing 3-IODO-1,2-propanediol having mucolytic activity | CARTER-WALLACE, INC. (US) | 1998-03-03 | — | — | US | disclosed |
| US-5066716-A | Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1991-11-19 | — | — | US | disclosed |